Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Testicular Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1Familial ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

X-Rays 4Phantoms, Imaging 4Cyclophosphamide 4Specimen Handling 3Melphalan 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2talazoparib 2selpercatinib 2palbociclib 2ivosidenib 2fludarabine 2cabozantinib 2Vemurafenib 2Topotecan 2Temozolomide 2Sirolimus 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2Filgrastim 2Bone Marrow Transplantation 2trioctyl phosphine oxide 1regorafenib 1racotumomab 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × trioctyl phosphine oxide × Genitourinary × Clear all
NCT00638898 2025-03-20

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSGenitourinarySarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Testicular Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡